Hannah P, Malizia A, Glover V, Bridges P, Sandler M
Department of Chemical Pathology, Queen Charlotte's Hospital, London, UK.
Drug Metabol Drug Interact. 1996;13(2):119-28. doi: 10.1515/dmdi.1996.13.2.119.
There is considerable evidence that subjects vulnerable to endogenous depression excrete less tyramine sulphate after an oral dose of free tyramine than controls (the tyramine test). In this study, 26 psychiatric inpatients, exhibiting a wide range of responses to the test, and 10 normal controls were challenged with oral doses of paracetamol and tyramine on two separate occasions. Urinary output of paracetamol sulphate and paracetamol glucuronide in all subjects was monitored but there were no significant correlations with tyramine sulphate output. Thus, the output of these metabolites appears to be under complex control, and paracetamol cannot be substituted for tyramine in the "tyramine test". The basic deficit responsible for low values in the tyramine test is unlikely to stem from sulphate depletion or a generalised disturbance of the sulphation system, and remains obscure.
有大量证据表明,易患内源性抑郁症的受试者在口服游离酪胺后,排出的硫酸酪胺比对照组少(酪胺试验)。在本研究中,26名对该试验反应范围广泛的精神科住院患者和10名正常对照者在两个不同场合接受了口服对乙酰氨基酚和酪胺的挑战。监测了所有受试者中硫酸对乙酰氨基酚和对乙酰氨基酚葡萄糖醛酸苷的尿量,但与硫酸酪胺的排出量没有显著相关性。因此,这些代谢物的排出似乎受复杂的控制,在“酪胺试验”中对乙酰氨基酚不能替代酪胺。酪胺试验中导致低值的基本缺陷不太可能源于硫酸盐消耗或硫酸化系统的普遍紊乱,并且仍然不清楚。